METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS

Introduction. In 70 % of patients with metastases of breast cancer in the ovaries, ovarian damage is detected simultaneously with the primary tumor, which affects the choice of tactics for diagnosis and treatment of such patients.Materials and methods. The data of 30 patients with breast cancer with...

Full description

Saved in:
Bibliographic Details
Main Authors: S. N. Tadzhibov, S. B. Polikarpova, T. M. Kochoyan, N. I. Mehtieva, R. A. Kerimov, A. I. Berishvili
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/539
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849773608541356032
author S. N. Tadzhibov
S. B. Polikarpova
T. M. Kochoyan
N. I. Mehtieva
R. A. Kerimov
A. I. Berishvili
author_facet S. N. Tadzhibov
S. B. Polikarpova
T. M. Kochoyan
N. I. Mehtieva
R. A. Kerimov
A. I. Berishvili
author_sort S. N. Tadzhibov
collection DOAJ
description Introduction. In 70 % of patients with metastases of breast cancer in the ovaries, ovarian damage is detected simultaneously with the primary tumor, which affects the choice of tactics for diagnosis and treatment of such patients.Materials and methods. The data of 30 patients with breast cancer with ovarian metastases and 35 patients with breast cancer without metastatic ovarian damage, which comprised the main and control groups. The groups were comparable in terms of main demographic and clinical features. Results. In the study of distant indicators, it is proved that the presence of metastases in the ovaries is a reliable adverse factor predicting a 3-year overall survival of patients older than 50 years who are in menopause and who received combined treatment.Conclusions. Surgical treatment significantly increases the 3and 5-year overall survival of breast cancer patients with ovarian metastases (83.3 %), while the combined treatment of such patients does not significantly affect overall survival despite the high sensitivity of breast cancer to chemotherapy. This may be due to the fact that the patients included in the study who received the combined treatment had metastases to other organs (liver, lungs, bones).
format Article
id doaj-art-2beb968dc4da4f9882e1a9d46c95dd8a
institution DOAJ
issn 1994-4098
1999-8627
language Russian
publishDate 2017-06-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-2beb968dc4da4f9882e1a9d46c95dd8a2025-08-20T03:01:59ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272017-06-01132273210.17650/1994-4098-2017-13-2-27-32534METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORSS. N. Tadzhibov0S. B. Polikarpova1T. M. Kochoyan2N. I. Mehtieva3R. A. Kerimov4A. I. Berishvili5I.M. Sechenov First Moscow State Medical University, Ministry Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry Health of RussiaResearch Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaResearch Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaResearch Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaResearch Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaIntroduction. In 70 % of patients with metastases of breast cancer in the ovaries, ovarian damage is detected simultaneously with the primary tumor, which affects the choice of tactics for diagnosis and treatment of such patients.Materials and methods. The data of 30 patients with breast cancer with ovarian metastases and 35 patients with breast cancer without metastatic ovarian damage, which comprised the main and control groups. The groups were comparable in terms of main demographic and clinical features. Results. In the study of distant indicators, it is proved that the presence of metastases in the ovaries is a reliable adverse factor predicting a 3-year overall survival of patients older than 50 years who are in menopause and who received combined treatment.Conclusions. Surgical treatment significantly increases the 3and 5-year overall survival of breast cancer patients with ovarian metastases (83.3 %), while the combined treatment of such patients does not significantly affect overall survival despite the high sensitivity of breast cancer to chemotherapy. This may be due to the fact that the patients included in the study who received the combined treatment had metastases to other organs (liver, lungs, bones).https://ojrs.abvpress.ru/ojrs/article/view/539breast cancermetastatic ovarian tumorslaparoscopyoverall survivaldisease-free survival
spellingShingle S. N. Tadzhibov
S. B. Polikarpova
T. M. Kochoyan
N. I. Mehtieva
R. A. Kerimov
A. I. Berishvili
METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
Опухоли женской репродуктивной системы
breast cancer
metastatic ovarian tumors
laparoscopy
overall survival
disease-free survival
title METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
title_full METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
title_fullStr METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
title_full_unstemmed METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
title_short METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
title_sort metastasis of breast cancer in the ovaries survival and prognostic factors
topic breast cancer
metastatic ovarian tumors
laparoscopy
overall survival
disease-free survival
url https://ojrs.abvpress.ru/ojrs/article/view/539
work_keys_str_mv AT sntadzhibov metastasisofbreastcancerintheovariessurvivalandprognosticfactors
AT sbpolikarpova metastasisofbreastcancerintheovariessurvivalandprognosticfactors
AT tmkochoyan metastasisofbreastcancerintheovariessurvivalandprognosticfactors
AT nimehtieva metastasisofbreastcancerintheovariessurvivalandprognosticfactors
AT rakerimov metastasisofbreastcancerintheovariessurvivalandprognosticfactors
AT aiberishvili metastasisofbreastcancerintheovariessurvivalandprognosticfactors